Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 127-141
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.127
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.127
Society | Year | Bleeding risk | Platelet count threshold (/μL) | Ref. |
National Institute for Health and Care Excellence | 2015 | Not classified | 50000 | National Clinical Guideline Centre (UK)[43] |
British Committee for Standards in Haematology | 2016 | Not classified | 50000 | Estcourt et al[37] |
Italian Association for the Study of Liver Diseases and the Italian Society of Internal Medicine | 2016 | Low | 50000 “this recommendation is supported only by biological plausibility” | Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)[42] |
International Coagulation in Liver Disease | 2017 | Intermediate | “Generally not recommended” | Intagliata et al[30] |
American Gastroenterological Association | 2019 | Intermediate | 50000 | O'Leary et al[44] |
Society of Interventional Radiology | 2019 | High | 50000 (20000 for transjugular liver biopsy) | Patel et al[31] |
American Association for the Study of Liver Diseases | 2020 | High | “Suggest individualized approaches” | Northup et al[47] |
American College of Gastroenterology | 2020 | Not classified | Correction not recommended | Simonetto et al[45] |
International Society on Thrombosis and Haemostasis | 2021 | High | Do not correct | Roberts et al[46] |
American Gastroenterological Association | 2021 | High | “Suggests against the preprocedural testing” | O'Shea et al[48] |
European Association for the Study of the Liver | 2022 | Low | “Cannot be generally indicated” | European Association for the Study of the Liver[49] |
Society | Year | Bleeding risk | Platelet count threshold (/μL) | Ref. |
American Society for Gastrointestinal Endoscopy | 2014 | Not classified | “Not recommended” | ASGE Standards of Practice Committee et al[61] |
National Institute for Health and Care Excellence | 2015 | Not classified | 50000 | National Clinical Guideline Centre (UK)[43] |
American Association for the Study of Liver Diseases | 2016 | Not classified | “Not provided a recommendation” | Garcia-Tsao et al[70] |
Italian Association for the Study of Liver Diseases and the Italian Society of Internal Medicine | 2016 | Moderate | 50000 “this recommendation is supported only by biological plausibility” | Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)[42] |
Austrian Society of Gastroenterology and Hepatology and the Austrian Society of Interventional Radiology | 2017 | Not classified | 50000 | Reiberger et al[71] |
International Coagulation in Liver Disease | 2017 | Low | “Generally not recommended” | Intagliata et al[30] |
American Gastroenterological Association | 2019 | Low | “Prophylaxis not required, although the authors recognize that risk assessment will vary in the clinical context” | O'Leary et al[44] |
American Association for the Study of Liver Diseases | 2020 | Low | “Suggest individualized approaches” | Northup et al[47] |
American College of Gastroenterology | 2020 | Not classified | Correction not recommended | Simonetto et al[45] |
International Society on Thrombosis and Haemostasis | 2021 | Low | Do not correct | Roberts et al[46] |
American Gastroenterological Association | 2021 | Low | “Suggests against the preprocedural testing” | O'Shea et al[48] |
European Association for the Study of the Liver | 2022 | High | “Generally not indicated” | European Association for the Study of the Liver[49] |
Society | Year | Bleeding risk | Platelet count threshold (/μL) | Ref. |
National Institute for Health and Care Excellence | 2015 | Not classified | 50000 | National Clinical Guideline Centre (UK)[43] |
International Coagulation in Liver Disease | 2017 | Intermediate | “Generally not recommended” | Intagliata et al[30] |
American Association for the Study of Liver Diseases | 2020 | High | “Suggest individualized approaches” | Northup et al[47] |
International Society on Thrombosis and Haemostasis | 2021 | High | Do not correct | Roberts et al[46] |
European Association for the Study of the Liver | 2022 | Low | “Cannot be generally indicated” | European Association for the Study of the Liver[49] |
- Citation: Biolato M, Vitale F, Galasso T, Gasbarrini A, Grieco A. Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines. World J Gastrointest Surg 2023; 15(2): 127-141
- URL: https://www.wjgnet.com/1948-9366/full/v15/i2/127.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.127